112 related articles for article (PubMed ID: 18299158)
1. Somatic chronic diseases and 6-year change in cognitive functioning among older persons.
Comijs HC; Kriegsman DM; Dik MG; Deeg DJ; Jonker C; Stalman WA
Arch Gerontol Geriatr; 2009; 48(2):191-6. PubMed ID: 18299158
[TBL] [Abstract][Full Text] [Related]
2. Cardiovascular diseases and decline in cognitive function in an elderly community population: the Edinburgh Artery Study.
Rafnsson SB; Deary IJ; Smith FB; Whiteman MC; Fowkes FG
Psychosom Med; 2007 Jun; 69(5):425-34. PubMed ID: 17556639
[TBL] [Abstract][Full Text] [Related]
3. Generalized atherosclerosis, cognitive decline, and depressive symptoms in old age.
Vinkers DJ; Stek ML; van der Mast RC; de Craen AJ; Le Cessie S; Jolles J; Westendorp RG; Gussekloo J
Neurology; 2005 Jul; 65(1):107-12. PubMed ID: 16009894
[TBL] [Abstract][Full Text] [Related]
4. The longitudinal relation between chronic diseases and depression in older persons in the community: the Longitudinal Aging Study Amsterdam.
Bisschop MI; Kriegsman DM; Deeg DJ; Beekman AT; van Tilburg W
J Clin Epidemiol; 2004 Feb; 57(2):187-94. PubMed ID: 15125629
[TBL] [Abstract][Full Text] [Related]
5. Comorbidity of somatic chronic diseases and decline in physical functioning:; the Longitudinal Aging Study Amsterdam.
Kriegsman DM; Deeg DJ; Stalman WA
J Clin Epidemiol; 2004 Jan; 57(1):55-65. PubMed ID: 15019011
[TBL] [Abstract][Full Text] [Related]
6. Impaired cognitive performance in asymptomatic peripheral arterial disease: relation to C-reactive protein and D-dimer levels.
Mangiafico RA; Sarnataro F; Mangiafico M; Fiore CE
Age Ageing; 2006 Jan; 35(1):60-5. PubMed ID: 16364935
[TBL] [Abstract][Full Text] [Related]
7. The effect of chronic benzodiazepine use on cognitive functioning in older persons: good, bad or indifferent?
Bierman EJ; Comijs HC; Gundy CM; Sonnenberg C; Jonker C; Beekman AT
Int J Geriatr Psychiatry; 2007 Dec; 22(12):1194-200. PubMed ID: 17407168
[TBL] [Abstract][Full Text] [Related]
8. Do subjective memory complaints predict cognitive dysfunction over time? A six-year follow-up of the Maastricht Aging Study.
Mol ME; van Boxtel MP; Willems D; Jolles J
Int J Geriatr Psychiatry; 2006 May; 21(5):432-41. PubMed ID: 16676287
[TBL] [Abstract][Full Text] [Related]
9. Fourteen-year longitudinal study of vascular risk factors, APOE genotype, and cognition: the ARIC MRI Study.
Knopman DS; Mosley TH; Catellier DJ; Coker LH;
Alzheimers Dement; 2009 May; 5(3):207-14. PubMed ID: 19362884
[TBL] [Abstract][Full Text] [Related]
10. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
[TBL] [Abstract][Full Text] [Related]
11. Influence of cognitive functioning on functional status in an older population: 3- and 6-year follow-up of the Maastricht Aging Study.
van Hooren SA; van Boxtel MP; Valentijn SA; Bosma H; Ponds RW; Jolles J
Int J Geriatr Psychiatry; 2005 Sep; 20(9):883-8. PubMed ID: 16116574
[TBL] [Abstract][Full Text] [Related]
12. Homocysteine and inflammation: predictors of cognitive decline in older persons?
van den Kommer TN; Dik MG; Comijs HC; Jonker C; Deeg DJ
Neurobiol Aging; 2010 Oct; 31(10):1700-9. PubMed ID: 19004529
[TBL] [Abstract][Full Text] [Related]
13. Relation between cardiovascular and metabolic disease and cognition in very old age: cross-sectional and longitudinal findings from the berlin aging study.
Verhaegen P; Borchelt M; Smith J
Health Psychol; 2003 Nov; 22(6):559-69. PubMed ID: 14640852
[TBL] [Abstract][Full Text] [Related]
14. The course of cognitive decline in older persons: results from the longitudinal aging study amsterdam.
Comijs HC; Dik MG; Deeg DJ; Jonker C
Dement Geriatr Cogn Disord; 2004; 17(3):136-42. PubMed ID: 14739534
[TBL] [Abstract][Full Text] [Related]
15. Postprandial plasma glucose excursions and cognitive functioning in aged type 2 diabetics.
Abbatecola AM; Rizzo MR; Barbieri M; Grella R; Arciello A; Laieta MT; Acampora R; Passariello N; Cacciapuoti F; Paolisso G
Neurology; 2006 Jul; 67(2):235-40. PubMed ID: 16864814
[TBL] [Abstract][Full Text] [Related]
16. Frequency and prognostic value of cognitive disorders in stroke patients.
Leśniak M; Bak T; Czepiel W; Seniów J; Członkowska A
Dement Geriatr Cogn Disord; 2008; 26(4):356-63. PubMed ID: 18852488
[TBL] [Abstract][Full Text] [Related]
17. Measuring cognitive function with age: the influence of selection by health and survival.
Euser SM; Schram MT; Hofman A; Westendorp RG; Breteler MM
Epidemiology; 2008 May; 19(3):440-7. PubMed ID: 18414086
[TBL] [Abstract][Full Text] [Related]
18. Change in sensory functioning predicts change in cognitive functioning: results from a 6-year follow-up in the maastricht aging study.
Valentijn SA; van Boxtel MP; van Hooren SA; Bosma H; Beckers HJ; Ponds RW; Jolles J
J Am Geriatr Soc; 2005 Mar; 53(3):374-80. PubMed ID: 15743277
[TBL] [Abstract][Full Text] [Related]
19. Association of diabetes, homocysteine, and HDL with cognition and disability after stroke.
Newman GC; Bang H; Hussain SI; Toole JF
Neurology; 2007 Nov; 69(22):2054-62. PubMed ID: 18040011
[TBL] [Abstract][Full Text] [Related]
20. The role of coping resources on change in well-being during persistent health decline.
Jonker AA; Comijs HC; Knipscheer KC; Deeg DJ
J Aging Health; 2009 Dec; 21(8):1063-82. PubMed ID: 19833864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
